We use cookies

Our website uses essential cookies and, with your consent, additional cookies to measure performance and improve our services. Cookie Policy.

You can change your choice at any time.

MMedXYNews
HomeVideos
MedXY AI/MedXY News/Section: Gastroenterology

Early Enteral Nutrition Reduces Postoperative Complications in High-Risk Pancreatoduodenectomy Patients

MedXY Editorial Team•Apr 26, 2026•Gastroenterology
clinical trialPancreatoduodenectomy术后并发症肠内营养

Background

Pancreatoduodenectomy remains one of the most complex abdominal surgeries with high postoperative morbidity rates (30-50%). Nutritional support strategies in the postoperative period are crucial yet controversial, particularly for patients with pre-existing nutritional risk. While enteral nutrition preserves gut barrier function and modulates systemic immunity, concerns remain about tube-related complications and patient tolerance.

Study Design

This multicenter, open-label, superiority RCT (NUTRIWHI) enrolled 144 patients (142 randomized) with Nutritional Risk Screening scores ≥3 across Swiss and French tertiary centers from 2021-2024. Patients were allocated 1:1 to early enteral nutrition (EEN) via nasojejunal tube started immediately postoperatively (with progressive oral intake) or oral nutrition (ON) alone. Parenteral nutrition protocols were standardized in both arms. Primary endpoint was 90-day complication burden measured by Comprehensive Complication Index (CCI).

Key Findings

The EEN group showed significantly lower mean 90-day CCI (25.5 vs 35.8; mean difference 10.3, 95% CI 1.8-18.8; P=.02), representing a clinically meaningful 29% reduction in complication burden. While overall morbidity rates showed no statistical difference (45/59 vs 51/59; RR 1.13, 95% CI 0.9-1.9), EEN demonstrated numerical advantages across multiple secondary endpoints including infectious complications (28.8% vs 35.6%) and pulmonary complications (13.6% vs 20.3%). Tube-related adverse events occurred in 23.7% of EEN patients requiring replacement.

Clinical Implications

These findings support EEN as the preferred nutritional strategy for high-risk patients undergoing pancreatoduodenectomy. The 10.3-point CCI reduction suggests substantial clinical benefit, as a 10-point difference is considered the minimal clinically important difference for this scale. Institutions should prioritize nasojejunal tube placement protocols and staff training to minimize tube displacement issues.

Conclusion

The NUTRIWHI trial provides Level 1 evidence that early enteral nutrition reduces postoperative complication burden in nutritionally vulnerable pancreatoduodenectomy patients. These results should inform enhanced recovery protocols and nutritional support guidelines for pancreatic surgery.

This article was created using several editorial tools, including AI, as part of the process. Human editors reviewed this content before publication.

Related articles

Open language-specific specialty feeds and department pages.

Reevaluating Angiography in the Diagnosis and Management of Intraluminal Hemorrhage Following Pancreatoduodenectomy: Insights from 115 Cases Among 3,011 SurgeriesThis study highlights the diagnostic and therapeutic value of angiography in intraluminal postpancreatoduodenectomy hemorrhage, revealing its superiority in bleeding source localization and effective hemostasis compared to other modalities.Sep 17, 2026Intraoperative Botulinum Toxin Injection to Reduce Postoperative Sialocele After Parotidectomy: A Retrospective Cohort AnalysisThis study suggests intraoperative botulinum toxin may reduce sialocele formation after parotidectomy, though larger prospective trials are needed to confirm efficacy and guide clinical use.Sep 15, 2026Impact of Severe Anastomotic Leak After Esophagectomy on Long-Term Survival: Insights from a Modern Multicenter CohortA large European study shows that severe anastomotic leaks requiring surgical reintervention after esophagectomy significantly reduce long-term survival and increase postoperative mortality, underscoring the need for targeted management strSep 12, 2026
Loading comments...
MedXY briefing

Get the free newsletter

Evidence-led clinical news, trends, and analysis—delivered to your inbox.

Ask MedXY AI

Most popular

Intimate Health
Five Benefits for Women Continuing Sexual Activity After Menopause
Intimate Health
Why Some Women Have a Strong Sex Drive—And Why Men Shouldn't Worry About It
Nursing & care
How often should a couple have sex?
Intimate Health
Classic Intimacy Recommendations: How to Help Women Reach Orgasm and Enjoy Mutual Pleasure
Intimate Health
What Makes a Woman "Physiologically Addicted" Is Never Money, But These Two Relationship Qualities
© 2026 MedXY
Contact usAbout usPrivacy PolicyMedXY story
Evaluating Cusatuzumab Combined with Venetoclax ± Azacitidine in Unfit Newly Diagnosed AML: Insights from the Phase Ib ELEVATE Trial
The phase Ib ELEVATE study demonstrates that cusatuzumab combined with venetoclax and azacitidine offers a promising tolerable and effective frontline therapy for patients with newly diagnosed acute myeloid leukemia ineligible for intensive
Sep 9, 2026
Therapeutic Hypothermia at 35°C vs. Controlled Normothermia in ICU Heatstroke: Insights from a Pilot RCTA pilot randomized trial comparing targeted temperature management at 35°C versus normothermia in intubated heatstroke patients showed no survival or neurological benefit from hypothermia but increased gastrointestinal injury and arrhythmiaSep 3, 2026
Impact of Weight-Loss Methods on Post-Bariatric Body Contouring Surgery Outcomes: A Comparative AnalysisThis study examines complication rates following body-contouring surgeries in patients after weight loss via bariatric surgery, GLP-1 receptor agonists, combination therapy, or lifestyle changes, finding modality-independent risk but highliSep 2, 2026